A language takes work off your hands, gives it to a compiler, runtime, or toolchain, and charges you somewhere else.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursive’s $400 million outlay represents the bulk of the company’s fundraising to date.

Jack Clark, Anthropic’s co-founder, left on paternity leave last November. When he returned in February, he was surprised to ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...